Polymorphism in semaphorin 5A (Sema5A) gene is not a marker of Parkinson's disease risk
10.1016/j.neulet.2006.01.038
Saved in:
Main Authors: | Bialecka M., Kurzawski M., Klodowska-Duda G., Opala G., Tan E.-K., Drozdzik M. |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/149648 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinsons disease, levodopa treatment response, and complications
by: Bialecka M., et al.
Published: (2018) -
Analysis of LRRK2 G2019S and I2020T mutations in Parkinson's disease
by: Bialecka M., et al.
Published: (2018) -
Analysis of LINGO1 (rs9652490) polymorphism in sporadic Parkinson's disease in a Polish population, and a meta-analysis
by: Białecka M., et al.
Published: (2018) -
Characterization of Sema5A/plexin-B3 signaling in the oligodendrocyte cell line OLN-93
by: YANG JIA
Published: (2011) -
Analysis of MDR1 haplotypes in Parkinson's disease in a white population
by: Tan, E.-K., et al.
Published: (2014)